Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
China · Delayed Price · Currency is CNY 57.95
+2.59 (4.68%)
At close: Mar 6, 2026
SHA:688513 Market Cap
SHA:688513 has a market cap or net worth of 10.1 billion as of March 6, 2026. Its market cap has increased by 91.87% in one year.
Market Cap
10.10B
Enterprise Value
8.67B
Revenue
1.33B
Ranking
n/a
PE Ratio
35.55
Stock Price
57.95
Market Cap Chart
Since September 2, 2020, SHA:688513's market cap has increased from 8.97B to 10.10B, an increase of 12.60%. That is a compound annual growth rate of 2.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 10.10B | -5.85% |
| Dec 31, 2025 | 10.73B | 104.34% |
| Dec 31, 2024 | 5.25B | -31.43% |
| Dec 29, 2023 | 7.66B | 4.83% |
| Dec 30, 2022 | 7.31B | 31.12% |
| Dec 31, 2021 | 5.57B | -2.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengdu Olymvax Biopharmaceuticals | 11.58B |
| Hualan Biological Vaccine | 11.55B |
| Chengzhi | 10.85B |
| HitGen | 10.83B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 10.70B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 10.66B |
| Liaoning Chengda Biotechnology | 10.39B |
| Aurisco Pharmaceutical | 10.37B |